03/04/2026 | Press release | Distributed by Public on 03/05/2026 09:12
The University of Toledo UToledo inaugurated the Northwest Ohio Cancer Research Institute with a ceremony that included University administrators and institute members on Tuesday, March 3, in the Health Education Building on the Health Science Campus.
Among the program's speakers was Dr. Jian-Ting Zhang, the director of the Northwest Ohio Cancer Research Institute, UToledo President, Dr. James Holloway, as well as recorded remarks from a broad range of elected officials including both Ohio U.S. Senators.
The Northwest Ohio Cancer Research Institute aims to advance the detection, diagnosis and treatment of cancer by facilitating interdisciplinary collaboration among clinicians and researchers at UToledo as well as partners including ProMedica.
More than 60 experts have been identified for inaugural membership, including more than 50 UToledo faculty whose active cancer research is supported by nearly $13 million in grants from federal agencies like the National Institutes of Health.
Members will collaborate through working groups established to specialize in breast, pancreatic and prostate cancer. They will also benefit from shared resources including service cores designed to support high-impact cancer research and to translate laboratory discoveries into patient-centered care innovations.
From left, Dr. Imran Ali, dean of the College of Medicine and Life Sciences; Dr. Mitchell McKinney, UToledo provost; Dr. James Holloway, UToledo president; Dr. Jian-Ting Zhang, a professor and the inaugural director of the Northwest Ohio Cancer Research Institute; and Dr. Grace Bochenek, vice president of research.
Dr. Jian-Ting Zhang, a professor and the inaugural director of the Northwest Ohio Cancer Research Institute.